Doxorubicin hydrochloride
Doxorubicin hydrochloride is a cytotoxic agent used in the treatment of various types of cancer. It is an anthracycline antibiotic that intercalates with DNA and inhibits DNA and RNA synthesis. Doxorubicin hydrochloride is commonly used in the management of solid tumors and hematological malignancies.
Lab products found in correlation
14 protocols using doxorubicin hydrochloride
Evaluating Cytotoxicity of IR700DX-mbc94
Synthesis and Characterization of Lipid-PEG Conjugates
glycol 2000-hydrazone-C18 (PHC), and polyethylene glycol 2000-amide-C18
(PAC) were synthesized following our previously published methods.31 (link),34 Doxorubicin hydrochloride was from Fisher Scientific Co. (Pittsburgh,
PA). Zoledronic acid, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), PLGA (752H), and poly-
(St. Louis, MO). Mannose was from Tokyo Chemical Industry Co., Ltd.
(Portland, OR). Hematoxylin-eosin (H&E) and anti-CD31 antibody
were from Abcam (Cambridge, MA). Hoechst 33342 was from AnaSpec, Inc.
(Fremont, CA). The 5-bromo-2′-deoxyuridine (BrdU) and primary
BrdU monoclonal antibody were from BD Biosciences (San Jose, CA).
Anti-CD206, RM0029-11H3, and FITC-labeled Anti-CD206 antibody were
from Santa Cruz Biotechnology, Inc. (Dallas, TX). Solvents used in
chemical synthesis were of analytical grade.
Doxorubicin AML Murine Model
Liposomal Doxorubicin Formulation and Characterization
(DPPC), 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine
(MSPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG2000), cholesterol,
and hydrogenated-
purchased from Avanti Polar Lipid. Doxorubicin hydrochloride was purchased
from Fisher Scientific.
LTSLs and NTSLs were synthesized by
a reverse-phase evaporation method.56 (link)−58 (link) Briefly, 5 mg of lipid
(for LTSLs: DPPC–MSPC–DSPE-PEG2000 = 90:10:4; for NTSLs:
HSPC–CHOL–DSPE-PEG2000 = 75:50:3 in molar ratio)59 (link),60 (link),64 (link),65 (link) was dissolved in 1 mL of chloroform, then dried using nitrogen air
and subsequent vacuum. To form the liposomes, the lipid film was hydrated
with a 300 mM citrate buffer (pH 4.0) for 60 min (at 55 °C for
LTSLs and 60 °C for NTSLs). The liposomes were then extruded
10 times through a 400 nm and a 100 nm polycarbonate membrane to obtain
the desired size. The outside pH of the liposome solution was titrated
to pH 7.5 using 0.5 M sodium carbonate. As a result, a pH gradient
was generated across the lipid bilayer.61 (link)−63 (link) DOX was then added to
the liposome solution at a 1:20 DOX/lipid weight ratio and mixed for
60 min (at 37 °C for LTSLs and 60 °C for NTSLs). The final
product was passed through a PD10 column to remove excess DOX.
Doxorubicin-Induced Apoptosis Assay
Verteporfin and Verapamil Cytotoxicity Assay
Cyclodextrin-Based Drug Delivery System
Chemical Compounds for Cell Biology
Radiolabeled Antibody Conjugate Synthesis
Hyaluronic Acid-Based Nanoparticle Formulation
weight hyaluronic acid was purchased from Glycosan
Biosystems (Salt Lake, UT). Bifunctionalized poly(ethylene glycol)
with thiol and amine functionalizations, N-(3-(dimethylamino)propyl)-N′-ethylcarbodiimide hydrochloride (EDC), N-hydroxysuccinimide (NHS), sodium borohydride, deuterium
oxide (D2O), and bovine hyaluronidase were purchased from
Sigma-Aldrich; doxorubicin hydrochloride, auric chloride (HAuCl3), and adipic dihydrazide were purchased from Fischer Scientific.
Dulbecco’s modified Eagle’s medium (DMEM) with 4.5 and
1 mg/mL
fetal bovine serum (FBS) were purchased from Worldwide Medical Supplies.
CD44-directed DNA aptamer and the randomized version of the aptamer
sequence were purchased from Integrated DNA Technologies (IDT). The
Milli-Q water used in all experiments was obtained from a three-stage
Millipore Milli-Q plus 185 purification system (Millipore Corporation),
with a resistivity greater than 18.2 MΩ cm.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!